Management of platelet-directed pharmacotherapy in patients with atherosclerotic coronary artery disease undergoing elective endoscopic gastrointestinal procedures.

Published

Journal Article

The periprocedural management of patients with atherosclerotic coronary heart disease, including those who have heart disease and those who are undergoing percutaneous coronary intervention and stent placement who might require temporary interruption of platelet-directed pharmacotherapy for the purpose of an elective endoscopic gastrointestinal procedure, is a common clinical scenario in daily practice. Herein, we summarize the available information that can be employed for making management decisions and provide general guidance for risk assessment.

Full Text

Duke Authors

Cited Authors

  • Becker, RC; Scheiman, J; Dauerman, HL; Spencer, F; Rao, S; Sabatine, M; Johnson, DA; Chan, F; Abraham, NS; Quigley, EMM; American College of Cardiology, ; American College of Gastroenterology,

Published Date

  • December 8, 2009

Published In

Volume / Issue

  • 54 / 24

Start / End Page

  • 2261 - 2276

PubMed ID

  • 19942393

Pubmed Central ID

  • 19942393

Electronic International Standard Serial Number (EISSN)

  • 1558-3597

Digital Object Identifier (DOI)

  • 10.1016/j.jacc.2009.09.012

Language

  • eng

Conference Location

  • United States